|
Market Cap (25-Jun) $22,910,358 (1,730th) |
Close (30-Jun) $0.020 |
Volume (30-Jun) 31,196 |
Shortsold (26-May) 1,000,000 (0.04%) (508th) |
|
52w High $1.10 |
52w Low $0.330 |
P/E 19.69 |
EPS 0.04 |
BXN released this announcement to the ASX on 24 October 2022, 8:20. The announcement is marked as price sensitive, and is 2 page(s) in length and 231.4kb in size.
You can view all announcements from BXN and see how they appear on a price chart on the announcements page.
At the date of this announcement, BXN was 0.000% short sold according to ASIC data. It was ranked the 595th most shorted stock on the ASX. It is now ranked as the 508th most shorted stock on the ASX with 0.044% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from BXN | |
|---|---|
| Bioxyne Launches BLS Clinics - Online Healthcare | 13 June 2023, 9:05 |
| Becoming a substantial holder | 8 June 2023, 16:36 |
| Becoming a substantial holder | 31 May 2023, 17:30 |
| Joins Asian Partner & Sells 49% of Direct Selling Business | 24 October 2022, 8:20 |
| AGM Date and Closing Date for Director Nominations | 4 October 2022, 14:46 |
| Appendix 4G and Corporate Governance Statement | 30 September 2022, 12:33 |
| Annual Report to shareholders | 30 September 2022, 12:15 |
You must be logged in to post a reply.
Bioxyne 